Tibet Aim Pharm Inc Capital Reinvestment Ratio
Tibet Aim Pharm Inc capital reinvestment ratio. Tibet Aim Pharm Inc (002826) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥87.55 Million) in capital expenditures (CN¥3.02 Million). Check total reinvestment intensity of Tibet Aim Pharm Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tibet Aim Pharm Inc (2013–2025)
Capital reinvestment ratio of Tibet Aim Pharm Inc from 2013 to 2025. This chart tracks Tibet Aim Pharm Inc's Capital Reinvestment Ratio across 12 annual periods. Also explore net asset momentum of Tibet Aim Pharm Inc to track the company's year-over-year net asset growth rate.
Tibet Aim Pharm Inc Capital Reinvestment Ratio by Year (2013–2025)
Tibet Aim Pharm Inc capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see 002826 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥123.72 Million | CN¥8.50 Million | ▼ -37.4% |
| 2024 | 0.11x | CN¥111.57 Million | CN¥12.24 Million | ▲ +475.7% |
| 2023 | 0.02x | CN¥166.88 Million | CN¥3.18 Million | ▼ -59.2% |
| 2022 | 0.05x | CN¥68.45 Million | CN¥3.20 Million | ▼ -79.7% |
| 2021 | 0.23x | CN¥109.52 Million | CN¥25.20 Million | ▼ -39.1% |
| 2020 | 0.38x | CN¥101.74 Million | CN¥38.43 Million | ▼ -86.9% |
| 2019 | 2.88x | CN¥59.20 Million | CN¥170.45 Million | ▼ -43.4% |
| 2018 | 5.09x | CN¥13.31 Million | CN¥67.72 Million | ▲ +426.8% |
| 2017 | 0.97x | CN¥77.29 Million | CN¥74.62 Million | ▲ +198.0% |
| 2016 | 0.32x | CN¥57.18 Million | CN¥18.52 Million | ▼ -98.4% |
| 2014 | 20.66x | CN¥2.18 Million | CN¥45.12 Million | ▲ +3671.3% |
| 2013 | 0.55x | CN¥52.24 Million | CN¥28.62 Million | — |